247 related articles for article (PubMed ID: 22052762)
1. Focal therapy for clinically localized prostate cancer.
Marchetti P; Eggener S
Arch Esp Urol; 2011 Oct; 64(8):815-22. PubMed ID: 22052762
[TBL] [Abstract][Full Text] [Related]
2. Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities.
Eggener SE; Scardino PT; Carroll PR; Zelefsky MJ; Sartor O; Hricak H; Wheeler TM; Fine SW; Trachtenberg J; Rubin MA; Ohori M; Kuroiwa K; Rossignol M; Abenhaim L;
J Urol; 2007 Dec; 178(6):2260-7. PubMed ID: 17936815
[TBL] [Abstract][Full Text] [Related]
3. Minimally invasive treatment for localized prostate cancer.
Porres D; Pfister D; Heidenreich A
Minerva Urol Nefrol; 2012 Dec; 64(4):245-53. PubMed ID: 23288211
[TBL] [Abstract][Full Text] [Related]
4. New treatments for localized prostate cancer.
Marberger M; Carroll PR; Zelefsky MJ; Coleman JA; Hricak H; Scardino PT; Abenhaim LL
Urology; 2008 Dec; 72(6 Suppl):S36-43. PubMed ID: 19095127
[TBL] [Abstract][Full Text] [Related]
5. Cancer ablation with regional templates applied to prostatectomy specimens from men who were eligible for focal therapy.
Ward JF; Nakanishi H; Pisters L; Babaian RJ; Troncoso P
BJU Int; 2009 Aug; 104(4):490-7. PubMed ID: 19220260
[TBL] [Abstract][Full Text] [Related]
6. [Salvage treatments for prostatic radiation failure].
Baumert H
Cancer Radiother; 2010 Oct; 14(6-7):442-5. PubMed ID: 20801701
[TBL] [Abstract][Full Text] [Related]
7. Focal therapy for prostate cancer.
Polascik TJ; Mouraviev V
Curr Opin Urol; 2008 May; 18(3):269-74. PubMed ID: 18382236
[TBL] [Abstract][Full Text] [Related]
8. Focal therapy in the management of localized prostate cancer.
Nguyen CT; Jones JS
BJU Int; 2011 May; 107(9):1362-8. PubMed ID: 21223478
[TBL] [Abstract][Full Text] [Related]
9. Conventional treatments of localized prostate cancer.
Zerbib M; Zelefsky MJ; Higano CS; Carroll PR
Urology; 2008 Dec; 72(6 Suppl):S25-35. PubMed ID: 19095125
[TBL] [Abstract][Full Text] [Related]
10. Location of residual cancer after transrectal high-intensity focused ultrasound ablation for clinically localized prostate cancer.
Boutier R; Girouin N; Cheikh AB; Belot A; Rabilloud M; Gelet A; Chapelon JY; Rouvière O
BJU Int; 2011 Dec; 108(11):1776-81. PubMed ID: 21711432
[TBL] [Abstract][Full Text] [Related]
11. Evaluating localized prostate cancer and identifying candidates for focal therapy.
Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
[TBL] [Abstract][Full Text] [Related]
12. [Focal therapy and prostate cancer].
Lazzeri M; Losa A; Buffi N; Lughezzani G; Fossati N; Abrate A; Larcher A; Lista G; Mistretta A; Guazzoni G
Urologia; 2013; 80(4):283-9. PubMed ID: 24419922
[TBL] [Abstract][Full Text] [Related]
13. [Prostate cancer treatments in Belgium].
Kaitouni MI; Roumeguère T
Rev Med Brux; 2009 Sep; 30(4):270-8. PubMed ID: 19899373
[TBL] [Abstract][Full Text] [Related]
14. Transrectal high-intensity focused ultrasound for local treatment of prostate cancer: current role.
Chaussy CG; Thüroff S
Arch Esp Urol; 2011 Jul; 64(6):493-506. PubMed ID: 21791716
[TBL] [Abstract][Full Text] [Related]
15. Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy.
Kimura M; Mouraviev V; Tsivian M; Mayes JM; Satoh T; Polascik TJ
BJU Int; 2010 Jan; 105(2):191-201. PubMed ID: 19583717
[TBL] [Abstract][Full Text] [Related]
16. The current use and future trends of focal surgical therapy in the management of localized prostate cancer.
Barqawi AB; Crawford ED
Cancer J; 2007; 13(5):313-7. PubMed ID: 17921730
[TBL] [Abstract][Full Text] [Related]
17. Maximizing outcomes in genitourinary cancers across the treatment continuum.
Fitzpatrick JM; Bellmunt J; Dreicer R; Fleshner NE; Logothetis CJ; Moul JW; Tombal B; Zlotta A
BJU Int; 2011 Apr; 107 Suppl 2():1-12. PubMed ID: 21382149
[TBL] [Abstract][Full Text] [Related]
18. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience.
Blana A; Walter B; Rogenhofer S; Wieland WF
Urology; 2004 Feb; 63(2):297-300. PubMed ID: 14972475
[TBL] [Abstract][Full Text] [Related]
19. Appropriate patient selection in the focal treatment of prostate cancer: the role of transperineal 3-dimensional pathologic mapping of the prostate--a 4-year experience.
Barzell WE; Melamed MR
Urology; 2007 Dec; 70(6 Suppl):27-35. PubMed ID: 18194708
[TBL] [Abstract][Full Text] [Related]
20. Targeted prostate cancer ablation: energy options.
Coleman JA; Scardino PT
Curr Opin Urol; 2013 Mar; 23(2):123-8. PubMed ID: 23287462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
